Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adults between 19 and 75 years old based on the date of written agreement~* Those who are diagnosed with acute or chronic gastritis with at least one erosion observed on upper gastrointestinal endoscopy~* Those who had experienced one or more subjective symptoms of gastritis~Exclusion Criteria:~* Those who have had surgery to reduce gastric acid secretion, or gastric or esophageal surgery~* Those with history of clinically significant hepatic, renal, neurologic, pulmonary, endocrine, hematologic, cardiovascular or genitourinary disease that could affect the study results

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- DWP14012 X mg QD (Type: EXPERIMENTAL): * Morning: 1 tablet of DWP14012 X mg + 1 tablet of DWP14012 Y mg placebo~* Evening: 1 tablet of DWP14012 Y mg placebo
- DWP14012 Y mg BID (Type: EXPERIMENTAL): * Morning: 1 tablet of DWP14012 X mg placebo + 1 tablet of DWP14012 Y mg~* Evening: 1 tablet of DWP14012 Y mg
- placebo (Type: PLACEBO_COMPARATOR): * Morning: 1 tablet of DWP14012 X mg placebo + 1 tablet of DWP14012 Y mg placebo~* Evening: 1 tablet of DWP14012 Y mg placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).